Delivery Order SPE2DB24D9131-SPE2DB25FXRW2
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $66,328.98 contract is for the delivery of UPTRAVI 1,600 MCG tablets to support U.S. government medical requirements. DMS Pharmaceutical Group holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense Logistics Agency for a broad range of pharmaceutical products to meet the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $66,359.82 contract is for the delivery of the medication UPTRAVI 800 MCG tablets. The delivery order has a completion date of March 28, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA, valued at up to $4,999,999, to provide a range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $72,628.98 firm fixed-price delivery order is for the supply of UPTRAVI 800 MCG TABLET 60S, a prescription medication. The contract has an ultimate completion date of July 15, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The federal contract award, with ID SPE2DB22D9353|SPE2DB25FX1LM, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,644.18 firm fixed-price delivery order is for the supply of 4566595907 - UPTRAVI 1,600 MCG TABLET 60S, with a period of performance through November 27, 2024. This award is under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
- This federal contract award, valued at $75,379.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of UPTRAVI 800 MCG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This contract award is for the delivery of UPTRAVI 800 MCG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $69,320.52, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, running through September 24, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 indefinite delivery contract (IDC) with the...
- This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,297.66 firm fixed-price delivery order contract is for the supply of the prescription drug UPTRAVI 1,600 MCG TABLET 60S. The contract has a period of performance through June 4, 2025 and is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,644.18 firm fixed-price contract is for the supply of Uptravi 1,600 mcg tablets to support the medical needs of the U.S. Department of Defense (DoD) and its health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This federal contract award, valued at $75,556.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for UPTRAVI 800 MCG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- The federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 and running through December 31, 2025. This order, with a ceiling value of $69,320.52, is for the delivery of the pharmaceutical product UPTRAVI 800 MCG...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRW2Delivery Order
The Defense Logistics Agency awarded a $72,201.78 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of UPTRAVI 800 microgram tablets (60 count). Issued on September 26, 2025, with an ultimate completion date of October 20, 2025, this firm fixed-price delivery order carries no set-aside designation. The order represents a discrete task issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products for Department of Defense healthcare facilities. UPTRAVI is a branded pharmaceutical used in the treatment of pulmonary arterial hypertension, reflecting DLA's ongoing procurement of specialized medications to support military health system needs. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in defense procurement markets. The vendor's extensive portfolio of federal contract awards demonstrates consistent capability in delivering diverse pharmaceutical products, from oncology treatments to vaccines and specialty medications, directly supporting the medical supply requirements of military healthcare facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $72.2k | 9/26/25 |